Gainers

• Curanex Pharmaceuticals (NASDAQ:CURX) shares moved upwards by 57.7% to $0.5 during Thursday's regular session. The company's market cap stands at $8.9 million.
• Butterfly Network (NYSE:BFLY) shares rose 48.06% to $4.59. The company's market cap stands at $783.0 million. As per the press release, Q4 earnings came out today.
• Klotho Neurosciences (NASDAQ:KLTO) stock increased by 21.61% to $0.52. The market value of their outstanding shares is at $30.9 million.
• Healthcare Triangle (NASDAQ:HCTI) stock rose 20.91% to $7.03. The company's market cap stands at $4.3 million.
• LeMaitre Vascular (NASDAQ:LMAT) stock moved upwards by 19.06% to $108.8. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q4 earnings report came out yesterday.
• PMV Pharma (NASDAQ:PMVP) shares rose 18.74% to $1.33. The market value of their outstanding shares is at $59.5 million.

Losers

• uniQure (NASDAQ:QURE) stock declined by 29.4% to $17.57 during Thursday's regular session. The company's market cap stands at $1.5 billion.
• PROCEPT BioRobotics (NASDAQ:PRCT) stock declined by 22.48% to $21.58. The market value of their outstanding shares is at $1.5 billion. As per the news, the Q4 earnings report came out yesterday.
• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock fell 20.46% to $0.08.
• Nautilus Biotechnology (NASDAQ:NAUT) stock fell 19.9% to $2.31. The market value of their outstanding shares is at $365.0 million. The company's, Q4 earnings came out today.
• 20/20 Biolabs (NASDAQ:AIDX) shares fell 19.02% to $4.6. The company's market cap stands at $58.7 million.
• GoodRx Holdings (NASDAQ:GDRX) stock fell 18.37% to $2.0. The market value of their outstanding shares is at $880.3 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.